Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Alzheimer'S Research & Therapy
|
October 12, 2022
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study
Audrey Low, Maria A Prats-Sedano, Elizabeth McKiernan, et al.
Nucleic Acids Research
|
April 30, 2019
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins
Michael T Migawa, Wen Shen, W Brad Wan, et al.
Nature Communications
|
August 11, 2015
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
Kazutaka Nishina, Wenying Piao, Kie Yoshida-Tanaka, et al.
Nature Biotechnology
|
May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Wen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Cerebral Circulation - Cognition and Behavior
|
January 19, 2026
The international society of vascular behavioural and cognitive disorders: highlights from VasCog 2025 in the UK
Anna Marseglia, Roxana O Carare, Jessica L Teeling, et al.
Alzheimer'S Research & Therapy
|
August 7, 2025
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
Valerie Lohner, Amanpreet Badhwar, Flavie E Detcheverry, et al.
Nucleic Acids Research
|
August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
Brooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Molecular Neurodegeneration
|
April 14, 2026
Regional diffusion imaging measures to disentangle SVD-related hypertensive arteriopathy versus cerebral amyloid angiopathy
Sheelakumari Raghavan, Scott A Przybelski, Robel K Gebre, et al.
Nucleic Acids Research
|
July 5, 2014
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P Prakash, Mark J Graham, Jinghua Yu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 20, 2025
Associations of estrogen with modifiable and non-modifiable risk factors for dementia: A narrative review
Sarah Gregory, Katie Bridgeman, Hannah Darwin, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Alzheimer'S Research & Therapy
|
October 12, 2022
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study
Audrey Low, Maria A Prats-Sedano, Elizabeth McKiernan, et al.
Nucleic Acids Research
|
April 30, 2019
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins
Michael T Migawa, Wen Shen, W Brad Wan, et al.
Nature Communications
|
August 11, 2015
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
Kazutaka Nishina, Wenying Piao, Kie Yoshida-Tanaka, et al.
Nature Biotechnology
|
May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Wen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Cerebral Circulation - Cognition and Behavior
|
January 19, 2026
The international society of vascular behavioural and cognitive disorders: highlights from VasCog 2025 in the UK
Anna Marseglia, Roxana O Carare, Jessica L Teeling, et al.
Alzheimer'S Research & Therapy
|
August 7, 2025
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
Valerie Lohner, Amanpreet Badhwar, Flavie E Detcheverry, et al.
Nucleic Acids Research
|
August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
Brooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Molecular Neurodegeneration
|
April 14, 2026
Regional diffusion imaging measures to disentangle SVD-related hypertensive arteriopathy versus cerebral amyloid angiopathy
Sheelakumari Raghavan, Scott A Przybelski, Robel K Gebre, et al.
Nucleic Acids Research
|
July 5, 2014
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P Prakash, Mark J Graham, Jinghua Yu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 20, 2025
Associations of estrogen with modifiable and non-modifiable risk factors for dementia: A narrative review
Sarah Gregory, Katie Bridgeman, Hannah Darwin, et al.
Page
of 7